SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients

References

• Rahimi F, Abadi ATB. Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic–correspondence. Int j Surg. 2022;1:106994.
   Google Scholar
• Islam S, Islam T, Islam MR. New coronavirus variants are creating more challenges to global healthcare system: a brief report on the current knowledge. Clini Pathol. 2022;15:2632010X2210755. doi:10.1177/2632010X221075584
   Web of Science ®Google Scholar
• Are EB, Song Y, Stockdale JE, Tupper P, Colijn C. COVID-19 endgame: from pandemic to endemic? Vaccination, reopening and evolution in low- and high-vaccinated populations. J Theor Biol. 2023;559:111368. doi:10.1016/j.jtbi.2022.111368
   PubMed Web of Science ®Google Scholar
• Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741–745. doi:10.1126/science.abe6522
   PubMed Web of Science ®Google Scholar
• Saad-Roy CM, Morris SE, Baker RE, et al. Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease. J Royal Soc Inter. 2023;20(205):20230247. doi:10.1098/rsif.2023.0247
   PubMed Web of Science ®Google Scholar
• Nesteruk I. Endemic characteristics of SARS-CoV-2 infection. Sci Rep. 2023;13(1):14841. doi:10.1038/s41598-023-41841-8
   PubMed Web of Science ®Google Scholar
• Nesteruk I. Epidemic waves caused by SARS‐CoV‐2 omicron (B. 1.1. 529) and pessimistic forecasts of the COVID‐19 pandemic duration. MedComm. 2022;3(1). doi:10.1002/mco2.122
   PubMedGoogle Scholar
• Gupta P, Gupta V, Singh CM, Singhal L. Emergence of COVID-19 variants: An update. Cureus. 2023;15(7).
   Web of Science ®Google Scholar
• Gupta D, Biswas D, Kabiraj P. COVID-19 outbreak and Urban dynamics: regional variations in India. GeoJournal. 2022;87(4):2719–2737. doi:10.1007/s10708-021-10394-6
   PubMed Web of Science ®Google Scholar
• Méndez-Arriaga F. The temperature and regional climate effects on communitarian COVID-19 contagion in Mexico throughout Phase 1. Sci Total Environ. 2020;735:139560. doi:10.1016/j.scitotenv.2020.139560
   PubMed Web of Science ®Google Scholar
• Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nature Med. 2020;26(7):1017–1032. doi:10.1038/s41591-020-0968-3
   PubMed Web of Science ®Google Scholar
• Cherry JD, Krogstad P. SARS: the first pandemic of the 21st century. Pediatr Res. 2004;56(1):1–5. doi:10.1203/01.Pdr.0000129184.87042.Fc
   PubMed Web of Science ®Google Scholar
• Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. doi:10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• Devaux CA, Rolain J-M, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Micro Immun Infect. 2020;53(3):425–435. doi:10.1016/j.jmii.2020.04.015
   Web of Science ®Google Scholar
• Li J, Lai S, Gao GF, Shi W. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600(7889):408–418. doi:10.1038/s41586-021-04188-6
   PubMed Web of Science ®Google Scholar
• Alaiya A, Alshukairi A, Shinwari Z, et al. Alterations in the plasma proteome induced by SARS-CoV-2 and MERS-CoV reveal biomarkers for disease outcomes for COVID-19 patients. J Inflamm Res. 2021;14:4313–4328. doi:10.2147/jir.S322430
   PubMed Web of Science ®Google Scholar
• Tekle E, Gelaw Y, Asrie F. hematological profile changes among oral contraceptive users: a narrative review. J Blood Med. 2022;13:525–536. doi:10.2147/jbm.S379841
   PubMed Web of Science ®Google Scholar
• Abdullateef Abdullah Z, Fouad Ali L. Role of serum ferritin, d-dimer, and c-reactive protein parameters in COVID 19 severity. Arch Razi Inst Apr. 2023;78(2):737–742. doi:10.22092/ari.2022.359731.2466
   PubMedGoogle Scholar
• Alvarez M, Trent E, Goncalves BDS, et al. Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs. Front Aging Neurosci. 2022;14:1020092. doi:10.3389/fnagi.2022.1020092
   PubMed Web of Science ®Google Scholar
• Group BDW, Atkinson AJ Jr, Colburn WA, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
   PubMed Web of Science ®Google Scholar
• Hulkoti VS, Acharya S, Kumar S, et al. Association of serum ferritin with COVID-19 in a cross-sectional study of 200 intensive care unit patients in a rural hospital: is ferritin the forgotten biomarker of mortality in severe COVID-19? J Fam Med Primary Care. 2022;11(5):2045. doi:10.4103/jfmpc.jfmpc_1921_21
   PubMedGoogle Scholar
• Ye Q, Wang B, Mao J. Cytokine storm in COVID-19 and treatment. J Infect. 2020;80(6):607–613. doi:10.1016/j.jinf.2020.03.037
   PubMed Web of Science ®Google Scholar
• Pedersen SF, Ho Y-C. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202–2205. doi:10.1172/JCI137647
   PubMed Web of Science ®Google Scholar
• Lillicrap D. Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia. J Thromb Haemost. 2020;18(4):786–787. doi:10.1111/jth.14781
   PubMed Web of Science ®Google Scholar
• Sakthivadivel V, Bohra GK, Maithilikarpagaselvi N, et al. Association of inflammatory markers with COVID-19 outcome among hospitalized patients: Experience from a tertiary healthcare center in western India. Maedica. 2021;16(4):620–627. doi:10.26574/maedica.2021.16.4.620
   PubMedGoogle Scholar
• Dai W, Rao R, Sher A, Tania N, Musante CJ, Allen R. A prototype QSP model of the immune response to SARS‐CoV‐2 for community development. CPT: Pharmacometrics & Systems Pharmacology. 2021;10(1):18–29.
   PubMedGoogle Scholar
• Kaushal K, Kaur H, Sarma P, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022;67:172–181. doi:10.1016/j.jcrc.2021.09.023
   PubMed Web of Science ®Google Scholar
• Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146(1):1–7. doi:10.1016/j.jaci.2020.04.021
   PubMed Web of Science ®Google Scholar
• de Guadiana-Romualdo L G, Morell-García D, Rodríguez-Fraga O, et al. Cardiac troponin and COVID-19 severity: results from BIOCOVID study. Eur J Clin Invest. 2021;51(6):e13532. doi:10.1111/eci.13532
   PubMed Web of Science ®Google Scholar
• Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agent. 2020;56(2):106051. doi:10.1016/j.ijantimicag.2020.106051
   PubMed Web of Science ®Google Scholar
• Fialek B, Pruc M, Smereka J, et al. Diagnostic value of lactate dehydrogenase in COVID-19: a systematic review and meta-analysis. Cardiol J. 2022;29(5):751–758. doi:10.5603/CJ.a2022.0056
   PubMed Web of Science ®Google Scholar
• Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J Infect. 2020;81(4):647–679. doi:10.1016/j.jinf.2020.06.053
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Fu Z, et al. Potential factors for prediction of disease severity of COVID-19 patients. MedRxiv. 2020;2020.03. 20.20039818.
   Google Scholar
• El-Lateef AE A, Ismail MM, Thabet G, Cabrido NA. Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: Single center study in Makkah, Saudi Arabia. Saudi Med J. 2022;43(6):572–578. doi:10.15537/smj.2022.43.6.20210893
   PubMed Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368.
   Google Scholar
• Moon AM, ASt B. Elevated liver enzymes in patients with COVID-19: Look, but not too hard. Dig Dis Sci. 2021;66(6):1767–1769. doi:10.1007/s10620-020-06585-9
   PubMed Web of Science ®Google Scholar
• Motoc NS, Man MA, Urda AEC, Ruta VM, Todea DA, Pop CM. Neutrophil-to-Lymphocyte ratio and platelets-to-lymphocytes ratio in severe COPD exacerbation: the importance of obstructive sleep apnea. Eur Respir Soc. 2019.
   Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-date review. Frontiers in Pediatrics. 2021;8:607647. doi:10.3389/fped.2020.607647
   PubMed Web of Science ®Google Scholar
• Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A. COVID-19: why does disease severity vary among individuals? Respir Med. 2021;180:106356. doi:10.1016/j.rmed.2021.106356
   PubMed Web of Science ®Google Scholar
• Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–488. doi:10.4149/bll_2021_078
   PubMed Web of Science ®Google Scholar
• Wu L, Zou S, Wang C, Tan X, Yu M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China. BMC Cardiovar Disorder. 2019;19:1–5. doi:10.1186/s12872-019-1110-7
   PubMed Web of Science ®Google Scholar
• Tanislav C, Guenduez D, Liebetrau C, et al. Cardiac Troponin I: A valuable biomarker indicating the cardiac involvement in Fabry disease. PLoS One. 2016;11(6):e0157640. doi:10.1371/journal.pone.0157640
   PubMed Web of Science ®Google Scholar
• Lai P-H, Ding D-C. Acute liver injury in a COVID-19 infected woman with mild symptoms: a case report. World J Clini Case. 2023;11(2):472–478. doi:10.12998/wjcc.v11.i2.472
   PubMed Web of Science ®Google Scholar
• Yamane T. Statistics an Industry Analysis 2ndEd. New York: Harper & Row; 1967.
   Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Chen XH, Huang S, Kerr D. Biomarkers in clinical medicine. IARC Sci Publ. 2011;(163):303–322.
   PubMedGoogle Scholar
• Califf RM. Biomarker definitions and their applications. Exp Biol Med. 2018;243(3):213–221. doi:10.1177/1535370217750088
   PubMed Web of Science ®Google Scholar
• Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol. 2021;7(3):297–304. doi:10.5114/ceh.2021.109225
   PubMed Web of Science ®Google Scholar
• Palladino M. Complete blood count alterations in COVID-19 patients: a narrative review. Biochem Med (Zagreb). 2021;31(3):030501. doi:10.11613/bm.2021.030501
   PubMed Web of Science ®Google Scholar
• Ismail MM, Gamal T, Nur-Anna C, Cabrido N-A. Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance. Saudi Med J. 2022;43(6):572–578. doi:10.15537/smj.2022.43.6.20210893
   PubMed Web of Science ®Google Scholar
• Turgunova L, Mekhantseva I, Akhmaltdinova L, Kostinov M, Zhumadilova Z, Turmukhambetova A. Association of sTREM‐1 and neutrophil-to-Lymphocyte ratio as prognostic markers in COVID-19 short-and long-term mortality. J Inflamm Res. 2023;Volume 16:5807–5817. doi:10.2147/JIR.S435305
   Web of Science ®Google Scholar
• Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020;92(11):2409–2411. doi:10.1002/jmv.26097
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J med virol. 2020;92(7):791–796. doi:10.1002/jmv.25770
   PubMed Web of Science ®Google Scholar
• Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020;16:10.
   Google Scholar
• W-j G, Z-y N, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, et al. C-Reactive protein as a prognostic indicator in COVID-19 patients. Interdiscip Perspect Infect Dis. 2021;2021:5557582. doi:10.1155/2021/5557582
   PubMedGoogle Scholar
• Dhinata KS. Common change of complete blood count parameters in COVID-19: a literature review. J Med Health. 2021;3(2). doi:10.28932/jmh.v3i2.3097
   Google Scholar
• Vargas-Vargas M, Cortés-Rojo C. Ferritin levels and COVID-19. Rev Panam Salud Pública. 2020;44:e72.
   PubMed Web of Science ®Google Scholar
• Kurian SJ, Mathews SP, Paul A, et al. Association of serum ferritin with severity and clinical outcome in COVID-19 patients: an observational study in a tertiary healthcare facility. Clin Epidem Glob Health. 2023;21:101295. doi:10.1016/j.cegh.2023.101295
   PubMed Web of Science ®Google Scholar
• Alroomi M, Rajan R, Omar AA, et al. Ferritin level: a predictor of severity and mortality in hospitalized COVID‐19 patients. Immu Inflam Dis. 2021;9(4):1648–1655. doi:10.1002/iid3.517
   PubMed Web of Science ®Google Scholar
• Saputro TA, Purwaningsih NV, Ainutajriani A, Watoyani T. Correlation between Corona viruses disease (Covid-19) and C-Reactive protein (CRP) in patients at Haji Hospital Surabaya. Medicra. 2022;5(1):11–16. doi:10.21070/medicra.v5i1.1631
   Google Scholar
• Moneer M, Fouad SH, Allam MF, et al. Do CRP levels predict severity in COVID-19 hospitalized Egyptian patients? Micro Infect Dis. 2022;3(3):534–543.
   Google Scholar
• Fukui S, Ikeda K, Kobayashi M, et al. Predictive prognostic biomarkers in patients with COVID‑19 infection. Mol Med Rep. 2023;27(1):1–8.
   PubMed Web of Science ®Google Scholar
• Nemec HM, Ferenczy A, Christie BD 3rd, Ashley DW, Montgomery A. Correlation of D-dimer and outcomes in COVID-19 patients. Am Surg. 2022;88(9):2115–2118. doi:10.1177/00031348221091940
   PubMed Web of Science ®Google Scholar
• Yu B, Li X, Chen J, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. Journal of Thrombosis and Thrombolysis. 2020;50:548–557. doi:10.1007/s11239-020-02171-y
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao K, Wei H, et al. Dynamic relationship between D‐dimer and COVID‐19 severity. Br J Haematol. 2020;190(1):e24. doi:10.1111/bjh.16797
   PubMed Web of Science ®Google Scholar
• Lehmann A, Prosch H, Zehetmayer S, et al. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS One. 2021;16(10):e0258351. doi:10.1371/journal.pone.0258351
   PubMed Web of Science ®Google Scholar
• Kimura Y, Nakai Y, Shin J, et al. Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Sci Rep. 2021;11(1):20638. doi:10.1038/s41598-021-98253-9
   PubMed Web of Science ®Google Scholar
• Fazal M. C-reactive protein a promising biomarker of COVID-19 severity. Korea J Clini Lab Sci. 2021;53(3):201–207. doi:10.15324/kjcls.2021.53.3.201
   Google Scholar
• de Lima IC, de Menezes DC, Uesugi JHE, et al. Liver Function in patients with long-term coronavirus disease 2019 of up to 20 months: a cross-sectional study. Int J Environ Res Public Health. 2023;20(7):5281. doi:10.3390/ijerph20075281
   PubMedGoogle Scholar
• Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Hepatology. 2020;72(1):287–304. doi:10.1002/hep.31281
   PubMed Web of Science ®Google Scholar
• Medetalibeyoglu A, Catma Y, Senkal N, et al. The effect of liver test abnormalities on the prognosis of COVID-19. Ann. Hepatol. 2020;19(6):614–621. doi:10.1016/j.aohep.2020.08.068
   PubMed Web of Science ®Google Scholar
• Rasmi Y, Mosa OF, Alipour S, et al. Significance of cardiac troponins as an identification tool in COVID-19 patients using biosensors: An update. Front Mol Biosci. 2022;9:821155. doi:10.3389/fmolb.2022.821155
   PubMed Web of Science ®Google Scholar
• Saini RK, Saini N, Ram S, et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2022;98(1156):91–97. doi:10.1136/postgradmedj-2020-138930
   PubMed Web of Science ®Google Scholar
• Plantone D, Locci S, Bergantini L, et al. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J Neurol Neurosurg Psychiatry. 2022;93(12):1343–1348. doi:10.1136/jnnp-2022-329933
   PubMed Web of Science ®Google Scholar
• Papadopoulou G, Manoloudi E, Repousi N, Skoura L, Hurst T, Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 severity and persistence. Pathogens. 2022;11(3):311. doi:10.3390/pathogens11030311
   PubMed Web of Science ®Google Scholar
• Luglio M, Tannuri U, de Carvalho WB, et al. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics. 2020;75:e2250. doi:10.6061/clinics/2020/e2250
   Google Scholar
• Gerges Harb J, Noureldine HA, Chedid G, et al. SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review. Pathog Dis. 2020;78(4). doi:10.1093/femspd/ftaa033
   PubMed Web of Science ®Google Scholar
• Zhou H, Yang J, Zhou C, et al. A review of SARS-CoV2: compared with SARS-CoV and MERS-CoV. Front Med Lausanne. 2021;8:628370. doi:10.3389/fmed.2021.628370
   PubMed Web of Science ®Google Scholar
• Masters PS; Masters PS. The molecular biology of coronaviruses. Adv Virus Res. 2006;66:193–292. doi:10.1016/S0065-3527(06)66005-3
   PubMed Web of Science ®Google Scholar